GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Alphatec Holdings Inc (NAS:ATEC) » Definitions » Shares Outstanding (EOP)

ATEC (Alphatec Holdings) Shares Outstanding (EOP) : 142.1 Mil (As of Sep. 2024)


View and export this data going back to 2006. Start your Free Trial

What is Alphatec Holdings Shares Outstanding (EOP)?

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. Alphatec Holdings's shares outstanding for the quarter that ended in Sep. 2024 was 142.1 Mil.

Alphatec Holdings's quarterly shares outstanding increased from Jun. 2024 (141.2 Mil) to Sep. 2024 (142.1 Mil). It means Alphatec Holdings issued new shares from Jun. 2024 to Sep. 2024 .

Alphatec Holdings's annual shares outstanding increased from Dec. 2022 (106.6 Mil) to Dec. 2023 (139.2 Mil). It means Alphatec Holdings issued new shares from Dec. 2022 to Dec. 2023 .


Alphatec Holdings Shares Outstanding (EOP) Historical Data

The historical data trend for Alphatec Holdings's Shares Outstanding (EOP) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alphatec Holdings Shares Outstanding (EOP) Chart

Alphatec Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shares Outstanding (EOP)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 61.40 82.10 99.54 106.64 139.25

Alphatec Holdings Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Shares Outstanding (EOP) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 123.31 139.25 139.26 141.21 142.10

Competitive Comparison of Alphatec Holdings's Shares Outstanding (EOP)

For the Medical Devices subindustry, Alphatec Holdings's Shares Outstanding (EOP), along with its competitors' market caps and Shares Outstanding (EOP) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Alphatec Holdings's Shares Outstanding (EOP) Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Alphatec Holdings's Shares Outstanding (EOP) distribution charts can be found below:

* The bar in red indicates where Alphatec Holdings's Shares Outstanding (EOP) falls into.



Alphatec Holdings Shares Outstanding (EOP) Calculation

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. They have voting rights and represent ownership in the corporation by the person that holds the shares. They should be distinguished from treasury shares, which are shares held by the corporation itself, having no exercisable rights.

Shares outstanding can be calculated as either basic or fully diluted. The fully diluted shares outstanding count includes diluting securities, such as options, warrants or convertibles.

Please note: GuruFocus named Shares Outstanding (EOP) is the shares for that end of period. It is usually used to calculate balance sheet related items, such as Book Value per Share, etc. While Shares Outstanding (Diluted Average) and Shares Outstanding (Basic Average) are the weighted average shares over a period of time (a year, a quarter, or so). They are usually used to calculate income statement or cashflow statement related items, such as Earnings per Share (Diluted), etc.


Alphatec Holdings  (NAS:ATEC) Shares Outstanding (EOP) Explanation

A company may buy back shares or issue shares in any fiscal period. If a company buys back shares, we should observe that the total number of shares decline. If the company issues new shares, the number of shares outstanding increases.

Usually the presence of treasury shares and a history of buyback are good indicators that company has competitive advantage. But studies have shown that companies usually buy back at wrong time. Buying back shares below its intrinsic value increases value for remaining shareholders. Buying back overvalued shares destroys value for existing shareholders.


Be Aware

Warren Buffett looks for consistency and upward long term trend. Because of share repurchase it is possible for net earnings trend to differ from EPS trend. He preferred net income over EPS. The companies with durable competitive advantage companies report higher % net earnings to total revenues.

Important: If a company is showing net earnings history greater than 20% on total revenues, it is probably benefiting from a long term competitive advantage.

If net earnings is less than 10%, likely to be in a highly competitive business.


Alphatec Holdings Shares Outstanding (EOP) Related Terms

Thank you for viewing the detailed overview of Alphatec Holdings's Shares Outstanding (EOP) provided by GuruFocus.com. Please click on the following links to see related term pages.


Alphatec Holdings Business Description

Traded in Other Exchanges
Address
1950 Camino Vida Roble, Carlsbad, CA, USA, 92008
Alphatec Holdings Inc is a medical technology company focused on the designing, development, and advancement of products for the surgical treatment of spinal disorders associated with disease and degeneration, congenital deformities, and trauma. The company's spine approach technologies include Posterior Cervical Fusion, Anterior Cervical Discectomy and Fusion, Lateral Interbody Fusion, and Posterior Lumbar Interbody Fusion among others.
Executives
Patrick Miles director, officer: Executive Chairman 7475 LUSK BLVD., SAN DIEGO CA 92121
Evan Bakst director 225 CENTRAL PARK WEST, APT. 1605, NEW YORK NY 10024
David R Pelizzon director, 10 percent owner 2850 FRONTIER DR, WARSAW IN 46582
David M Demski director C/O GLOBUS MEDICAL, INC., 2560 GENERAL ARMISTEAD AVENUE, AUDUBON PA 19403
Tyson Eliot Marshall officer: GENERAL COUNSEL & CORP. SEC. 10680 TREENA STREET, SUITE 500, SAN DIEGO CA 92131
John Todd Koning officer: Chief Financial Officer C/O MASIMO CORPORATION, 52 DISCOVERY, IRVINE CA 92618
Quentin S. Blackford director 7475 LUSK BLVD., SAN DIEGO CA 92121
David Sponsel officer: EVP, Sales C/O ALPHATEC SPINE, INC., 5818 EL CAMINO REAL, CARLSBAD CA 92008
Scott Lish officer: SVP, Development C/O ALPHATEC SPINE, INC., 5818 EL CAMINO REAL, CARLSBAD CA 92008
Craig E Hunsaker officer: See Remarks C/O ALPHATEC HOLDINGS, INC., 5818 EL CAMINO REAL, CARLSBAD CA 92008
Tullis James L L director, 10 percent owner 100 FIRST STAMFORD PLACE, STAMFORD CT 06907
David H Mowry director 9775 TOLEDO, IRVINE CA 92618
Jennifer N. Pritzker 10 percent owner C/O SQUADRON CAPITAL LLC, 104 S. MICHIGAN AVENUE, SUITE 500, CHICAGO IL 60603
Elizabeth Ann Altman director 10070 BARNES CANYON ROAD, SAN DIEGO CA 92121
Paul Segal 10 percent owner 1700 BROADWAY, 35TH FLOOR, NEW YORK NY 10019